Skip To Content

ACD/Labs Blog

Sherry Myles
Pfizer’s 5 year data management journey has given them a global knowledgebase that manages chemical and analytical data across various workflows. Scientists are accessing data and saving time. Learn how ACD/Labs technologies are enabling their digital evolution strategy.

Sherry Myles
Digitalization is transforming research and development across pharma, biopharma, and chemical sciences. From predictive modeling to automated and digitalized workflows, scientists are finding innovative ways to bring together data, tools, and expertise to drive innovation. Join us as we bring together leading researchers and industry experts to explore practical applications of digital tools in real-world...

Sarah Srokosz
Coupling in proton NMR coupling contains information vital to elucidating chemical structures. Discover how recognizing multiplicity, coupling constants, and higher-order effects enables chemists to deduce structures quickly.

Sarah Srokosz
Explore how ASV transforms structure verification into a scalable, consistent and reliable process. This article was originally published on Technology Networks Structure verification in R&D Chemical structure verification is a tedious but critical task in the drug discovery and development pipeline. Despite the advances in automation, AI and high-throughput screening that have revolutionized many other...

Sherry Myles
ACD/Labs and MilliporeSigma Expand Partnership to Advance Digital, Sustainable Compound Verification & Quantification by NMR and IR Toronto, CANADA (May 22, 2025)—ACD/Labs is pleased to expand its partnership with MilliporeSigma (the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany), building on the 2023 collaboration that launched the first digital reference material (dRM)...